Diabetes lures pharma to the Gulf

Share this article:

Diabetes is a growing problem and pharmaceutical opportunity in Saudi Arabia. The Wall Street Journal outlines the health crisis that is increasingly visible during mall walks that double as a respite from the heat and a time to mingle over fast food.

The Journal also notes that governments in the Gulf have offered a mix of financial incentives to coax businesses to take manufacturing local, and that companies like Merck KGaA have partnered with local producers as a way of getting a foothold in the market.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M inVISION